Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Prime Medicine Inc

PRME
4,19
-0,20 (-4,56%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:44:57
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/11/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:06EDGAR2Form 8-K - Current report
12/11/202422:00GLOBEPrime Medicine Reports Third Quarter 2024 Financial Results..
06/11/202422:00GLOBEPrime Medicine to Participate in Upcoming Investor..
24/10/202414:04EDGAR2Form 8-K - Current report
24/10/202414:00GLOBEPrime Medicine Presents In Vivo Proof-of-Concept Data..
15/10/202414:00GLOBEPrime Medicine to Highlight New Preclinical Data, Including..
30/9/202413:38EDGAR2Form 8-K - Current report
30/9/202413:01GLOBEPrime Medicine Unveils Strategically Focused Pipeline
30/9/202413:00GLOBEPrime Medicine Announces Strategic Research Collaboration..
28/8/202414:00GLOBEPrime Medicine to Participate in Upcoming Investor..
08/8/202414:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202414:08EDGAR2Form 8-K - Current report
08/8/202414:00GLOBEPrime Medicine Reports Second Quarter 2024 Financial Results..
14/6/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:10EDGAR2Form 8-K - Current report
30/5/202414:00GLOBEPrime Medicine to Present at Upcoming Investor Conferences
21/5/202422:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/5/202422:03EDGAR2Form 8-K - Current report
13/5/202414:00GLOBEPrime Medicine to Present at H.C. Wainwright 2nd Annual..
10/5/202414:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202414:05EDGAR2Form 8-K - Current report
10/5/202414:00GLOBEPrime Medicine Reports First Quarter 2024 Financial Results..
08/5/202414:00GLOBEPrime Medicine Presents Preclinical Data Demonstrating..
01/5/202414:00GLOBEPrime Medicine to Participate in the 27th Annual Milken..
29/4/202413:00GLOBEPrime Medicine Announces FDA Clearance of Investigational..
23/4/202414:00GLOBEPrime Medicine to Present Preclinical Data Demonstrating..
01/3/202414:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/3/202414:04EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/3/202414:01EDGAR2Form 8-K - Current report
01/3/202414:00GLOBEPrime Medicine Reports Full Year 2023 Financial Results and..
28/2/202414:00GLOBEPrime Medicine to Participate in Upcoming Investor..
23/2/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202403:31EDGAR2Form SC 13D - General statement of acquisition of beneficial..
20/2/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:01GLOBEPrime Medicine Announces Closing of Upsized Public Offering..
16/2/202412:23EDGAR2Form 8-K - Current report
16/2/202412:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/2/202405:50GLOBEPrime Medicine Announces Pricing of Upsized Public Offering
15/2/202403:57EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
14/2/202423:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/202422:12EDGAR2Form 8-K - Current report
14/2/202422:05GLOBEPrime Medicine Announces Proposed Public Offering of Common..
25/1/202414:00GLOBEPrime Medicine Receives Up to $15 Million from Cystic..
08/1/202414:01EDGAR2Form 8-K - Current report
05/1/202423:03EDGAR2Form 8-K - Current report
05/1/202414:15EDGAR2Form 8-K - Current report
05/1/202414:00GLOBEPrime Medicine Appoints Allan Reine, M.D., as Chief..
Apertura: 4,338 Min: 4,21 Max: 4,43
Chiusura: 4,39

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network